Search Result "177Lu"
A Potencial Theranostic Agent for EGF-R Expression Tumors: 177Lu- DOTA-Nimotuzumab
Journal: Current Radiopharmaceuticals
Volume: 5 Issue: 4 Year: 2012 Page: 318-324
Author(s): Victoria Calzada,Xiuli Zhang,Marcelo Fernandez,Arlhee Diaz-Miqueli,Normando Iznaga-Escobar,Susan L. Deutscher,Henia Balter,Thomas P. Quinn,Pablo Cabral
Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma
Journal: Current Radiopharmaceuticals
Volume: 6 Issue: 1 Year: 2013 Page: 20-27
Author(s): Ada H. V. Repetto-Llamazares, Roy H. Larsen, Camilla Mollatt, Michael Lassmann, Jostein Dahle
177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma
Journal: Current Radiopharmaceuticals
Volume: 10 Issue: 1 Year: 2017 Page: 21-28
Author(s): Ximena Camacho,Victoria Calzada,Marcelo Fernandez,Omar Alonso,Roger Chammas,Eloisa Riva,Juan Pablo Gambini,Pablo Cabral
[177Lu]-DOTA0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma
Journal: Current Radiopharmaceuticals
Volume: 3 Issue: 1 Year: 2010 Page: 29-36
Author(s): Ganesan Vaidyanathan, Donna J. Affleck, Xiao-Guang Zhao, Stephen T. Keir, Michael R. Zalutsky
Studies on Efficacy of a Novel 177Lu-Labeled Porphyrin Derivative in Regression of Tumors in Mouse Model
Journal: Current Radiopharmaceuticals
Volume: 4 Issue: 2 Year: 2011 Page: 150-160
Author(s): Haladhar D. Sarma, Tapas Das, Sharmila Banerjee, Meera Venkatesh, Pandit B. Vidyasagar, Kaushala P. Mishra
Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic Study
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2018 Page: 146-153
Author(s): Mohini Guleria,Tapas Das,Chandan Kumar,Rohit Sharma,Jeyachitra Amirdhanayagam,Haladhar D. Sarma,Ashutosh Dash
Radiomics Analysis of 177Lu-PSMA I&T Radioligand Therapy Dosimetry in a Castration Resistant Metastatic Prostate Cancer Patient
Ebook: The Evolution of Radionanotargeting towards Clinical Precision Oncology: A Festschrift in Honor of Kalevi Kairemo
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9781681088655122010039
Real-World Evidence of Clinical Outcomes in Precision Radionuclide Oncology: The NIGHTCAP Study of 177Lu-PSMA in Metastatic Prostate Cancer
Journal: Current Pharmaceutical Design
Volume: 26 Issue: 31 Year: 2020 Page: 3799-3803
Author(s): J. Harvey Turner
Estimation of specific activity of 177Lu by `saturation assay` principle using DOTA as ligand
Journal: Current Radiopharmaceuticals
Volume: 8 Issue: 2 Year: 2015 Page: 123-128
Author(s): Ambikalmajan M.R. Pillai,Sudipta Chakraborty,Tapas Das
Synthesis and Ready to Use Kit Formulation of EDTMP for thePreparation of 177Lu-EDTMP as a Bone Palliation Radiopharmaceutical
Journal: Current Radiopharmaceuticals
Volume: 16 Issue: 1 Year: 2023 Page: 38-43
Author(s):